Skip to main content

Montana Cancer Consortium

EIN: 81-0503295Billings, MTZIP: 59102
G30 - Diseases, Disorders & Medical Disciplines501(c)(3)

Mission

The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer treatment to Montana, Idaho, and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Financials

YearRevenueExpensesAssets
2023$1.3M$0$723k
2022$607k$0$361k

Compensation

2023

Amanda Dinsdale
$0
$0
$0
$123,873
John Schallenkamp MD
$0
$0
$0
$0
Michelle Proper MD
$0
$0
$0
$0
Christopher Goulet MD
$0
$0
$0
$0
James Hueftle MD
$0
$0
$0
$0
Justin Thomas MD
$0
$0
$0
$0

2022

Amanda Dinsdale
$0
$0
$0
$109,777
Michelle Proper MD
$0
$0
$0
$0
Justin Thomas MD
$0
$0
$0
$0
John Schallenkamp MD
$0
$0
$0
$0
Christopher Goulet MD
$0
$0
$0
$0
James Hueftle MD
$0
$0
$0
$0
Benjamin Marchello MD
$0
$0
$0
$0

Similar Organizations

$659k revenue
Same sector (G30)Comparable revenue ($659k vs $1.3M)Comparable compensation levelsSimilar size (15 vs 16 executives)
$683k revenue
Same sector (G30)Comparable revenue ($683k vs $1.3M)Comparable compensation levelsSimilar size (15 vs 16 executives)
$644k revenue
Same sector (G30)Comparable revenue ($644k vs $1.3M)Comparable compensation levels
IMAGE REBORN INC

Salt Lake City, UT

$645k revenue
Same sector (G30)Comparable revenue ($645k vs $1.3M)Similar size (15 vs 16 executives)
$672k revenue
Same sector (G30)Comparable revenue ($672k vs $1.3M)Similar size (16 vs 16 executives)
$672k revenue
Same sector (G30)Comparable revenue ($672k vs $1.3M)Similar size (14 vs 16 executives)
$674k revenue
Same sector (G30)Comparable revenue ($674k vs $1.3M)Similar size (14 vs 16 executives)
Pathfinders

Aspen, CO

$681k revenue
Same sector (G30)Comparable revenue ($681k vs $1.3M)Comparable compensation levels
LIVING JOURNEYS

Crested Butte, CO

$641k revenue
Same sector (G30)Comparable revenue ($641k vs $1.3M)
$648k revenue
Same sector (G30)Comparable revenue ($648k vs $1.3M)
Data from IRS Form 990 filings (2022-2023).